## Biography

> _“The Filtricine approach is unique. It promises to feed the patients' bodies, not their cancers.”_

Dr. Lorenz advises Filtricine on medical strategy and clinical trial design. His expertise spans more than 20 years of drug development and clinical trial design. Previously, he held senior leadership positions at Johnson and Johnson, Cor Therapeutics, Orexigen, Catalyst Biosciences, and Corgentech. Dr. Lorenz earned his MD at Case Western Reserve University.

## Our Team

###### Dr. Grace Xiaolu Yang

COO, VP of Research & Co-founder

###### Mike Partsuf

Senior Food Scientist

###### Emily Sinovic

Public Relations Consultant

## Our Advisors

###### Dr. Mike P Snyder

Stanford University School of Medicine

###### Peter B Hutt

Senior Counsel at Covington & Burling LLP

###### Brad Barnes

Culinary Institute of America

###### Dr. Dariush Mozaffarian

Tufts University

###### Dr. Yung-Chi Cheng

Yale University School of Medicine

###### Dr. Danhua Xiao

Atlantic Health Metabolic Center

###### Dr. Joseph V Rodricks

Ramboll (formerly ENVIRON)

###### Alister Thomson

Bristol Myers Squibb (Former)

###### Jeff Depew

Sand Hill Angels

###### Dr. Wei Jiang

Medical Affairs at MorphoSys

## Our Board of Directors

###### Dr. Xiyan Li

Co-founder

###### Dr. Rami El Assal

Founding Partner at Boutique Venture Partners

###### Drew Lanza

Founding Partner at Berkeley Catalyst Fund

We are a clinical-stage biotechnology company based in the San Francisco Bay Area dedicated to developing novel food products for disease control.